Page 538 - IJB-10-4

International Journal of Bioprinting 3D printed substrate for adhesion tests

functional and non-functional pressure sensitive adhesives. 35. Wesley NO, Maibach HI. Racial (ethnic) differences in
AAPS PharmSciTech. 2010;11:278-284. skin properties: the objective data. Am J Clin Dermatol.
doi: 10.1208/s12249-009-9366-3 2003;4(12):843-860.
doi: 10.2165/00128071-200304120-00004
23. Mehdizadeh A, Ghahremani MH, Rouini MR, Toliyat
T. Effects of pressure sensitive adhesives and chemical 36. Man M, Xin S, Song S, et al. Variation of skin surface pH,
permeation enhancers on permeability of fentanyl through sebum content and stratum corneum hydration with age
excised rat skin. Acta Pharm. 2006;56(2):219-229. and gender in a large Chinese population. Skin Pharmacol
Physiol. 2009;22(4):190-199.
24. Ko C. Effect of skin penetration enhancers in transdermal
drug delivery adhesives on skin adhesion and irritation. Int doi: 10.1159/000231524
Symptom Control Rel Bio Mater. 1996;23:281-282. 37. Greenall J, Koczmara C, Cheng R, Hyland S. Safety issues
with fentanyl patches require pharmaceutical care. Can J
25. Lin S-Y, Lee C-J, Lin Y-Y. The effect of plasticizers on
compatibility, mechanical properties, and adhesion strength of Hosp Pharm. 2008;61(1):57-59.
drug-free Eudragit E films. Pharm Res. 1991;8(9):1137-1143. 38. Wichman K, David U. Overdose a risk of transdermal patch
doi: 10.1023/a:1015850301214 in diverse settings. Can Pharm J (Ott). 2005;138(7):65.
26. Horst A, McDonald F. Uncertain but not unregulated: medical 39. Schreier P, Traßl C, Altstädt V. Surface Modification of
product regulation in the light of three-dimensional printed Polypropylene Based Particle Foams. American Institute of
medical products. 3D Print Addit Manuf. 2020;7(5):248-257. Physics; 2014:378-382.
doi: 10.1089/3dp.2020.0076
40. Babu R, Chatterjee A, Singh M. Assessment of skin irritation
27. Ng WL, An J, Chua CK. Process, material, and regulatory and molecular responses in rat skin exposed to nonane,
considerations for 3D printed medical devices and tissue dodecane and tetradecane. Toxicol Lett. 2004;153(2):255-266.
constructs. Engineering. 2024;36:146-166. doi: 10.1016/j.toxlet.2004.04.036
doi: 10.1016/j.eng.2024.01.028
41. Ahaghotu E, Babu R, Chatterjee A, Singh M. Effect of methyl
28. Ohtsuki R, Sakamaki T, Tominaga S. Analysis of skin surface substitution of benzene on the percutaneous absorption and
roughness by visual assessment and surface measurement. skin irritation in hairless rats. Toxicol Lett. 2005;159(3):
Opt Rev. 2013;20:94-101. 261-271.
doi: 10.1007/s10043-013-0014-5 doi: 10.1016/j.toxlet.2005.05.020
29. FDSC. Surface Energy Measurment. 2022. 42. Boakye CH, Patel K, Doddapaneni R, et al. Ultra-flexible
https://fdsc.com nanocarriers for enhanced topical delivery of a highly lipophilic
antioxidative molecule for skin cancer chemoprevention.
30. Ganti SS, Bhattaccharjee SA, Murnane KS, Blough BE, Banga
AK. Formulation and evaluation of 4-benzylpiperidine Colloids Surf B Biointerfaces. 2016;143:156-167.
drug-in-adhesive matrix type transdermal patch. Int J doi: 10.1016/j.colsurfb.2016.03.036
Pharm. 2018;550(1-2):71-78. 43. Kanikkannan N, Burton S, Patel R, Jackson T, Shaik MS,
doi: 10.1016/j.ijpharm.2018.08.033 Singh M. Percutaneous permeation and skin irritation
of JP-8+ 100 jet fuel in a porcine model. Toxicol Lett.
31. Sun W, Grosser S, Kim C, Raney SG. Statistical considerations
and impact of the FDA draft guidance for assessing adhesion 2001;119(2):133-142.
with transdermal delivery systems and topical patches for doi: 10.1016/S0378-4274(00)00311-8
ANDAs. J Biopharm Stat. 2019;29(5):952-970. 44. Bagde A, Patel K, Mondal A, et al. Combination of UVB
doi: 10.1080/10543406.2019.1657440 absorbing titanium dioxide and quercetin nanogel for
skin cancer chemoprevention. AAPS PharmSciTech.
32. USFDA. Assessing Adhesion With Transdermal and Topical
Delivery Systems for ANDAs Draft Guidance for Industry; 2019;20(6):1-12.
2023. Accessed October 1. doi: 10.1208/s12249-019-1424-x
https://www.fda.gov/regulatory-information/search-fda- 45. Bagde A, Kouagou E, Singh M. Formulation of topical
guidance-documents/assessing-adhesion-transdermal- flurbiprofen solid lipid nanoparticle gel formulation
and-topical-delivery-systems-andas-draft-guidance- using hot melt extrusion technique. AAPS PharmSciTech.
industry 2022;23(7):257.
doi: 10.1208/s12249-022-02410-w
33. Firooz A, Sadr B, Babakoohi S, et al. Variation of biophysical
parameters of the skin with age, gender, and body region. 46. Salau O, Bagde A, Kalvala A, Singh M. Enhancement
ScientificWorldJournal. 2012;2012: 386936. of transdermal permeation of cannabinoids and their
doi: 10.1100/2012/386936 pharmacodynamic evaluation in rats. Int J Pharm.
2022;624(3):122016.
34. Couturaud V. Biophysical characteristics of the skin in
relation to race, sex, age, and site. In: Handbook of Cosmetic doi: 10.1016/j.ijpharm.2022.122016
Science and Technology; 2009:5-24. 47. Godugu C, Doddapaneni R, Patel AR, Singh R, Mercer R,
doi: 10.1201/b15273-3 Singh M. Novel gefitinib formulation with improved oral

Volume 10 Issue 4 (2024) 530 doi: 10.36922/ijb.3735